Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Lansoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin Plans ADR Ratio Change Under Its Depository Receipt Program
    Amarin Plans ADR Ratio Change Under Its Depository Receipt Program

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041242/18362/en/Amarin-Announces-Plan-to-Initiate-a-Ratio-Change-Under-Its-American-Depository-Receipt-ADR-Program.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    Amarin Reports Q4 Results, Business Update, Announces Corporate Action
    Amarin Reports Q4 Results, Business Update, Announces Corporate Action

    12 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/12/3041230/18362/en/Amarin-Reports-Fourth-Quarter-Financial-Results-Business-Update-and-Announces-Important-Corporate-Action.html

    GLOBENEWSWIRE
    12 Mar 2025
    Share Share
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis
    Amarin Marks Milestone for VASCEPA®/VAZKEPA® - REDUCE-IT Analysis

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033894/18362/en/Amarin-Marks-Key-Milestone-for-VASCEPA-VAZKEPA-Icosapent-Ethyl-Publication-of-Post-Hoc-Analysis-of-REDUCE-IT-in-Journal-of-the-American-Heart-Association-Reports-Benefit-on-Top-of-.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    Amarin Receives National Reimbursement for VAZKEPA® in Austria
    Amarin Receives National Reimbursement for VAZKEPA® in Austria

    25 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/25/3031955/18362/en/Amarin-Receives-National-Reimbursement-for-VAZKEPA-in-Austria.html

    GLOBENEWSWIRE
    25 Feb 2025
    Share Share
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025
    Amarin to Report Q4 and Full Year 2024 Results on March 12, 2025

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/19/3028763/18362/en/Amarin-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Host-Conference-Call-on-March-12-2025.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Amarin Appoints Peter Fishman Chief Financial Officer
    Amarin Appoints Peter Fishman Chief Financial Officer

    13 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/13/2996829/18362/en/Amarin-Appoints-Peter-Fishman-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    13 Dec 2024
    Share Share